|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Operating Activities: | |
| Net loss | |
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |
| Depreciation and amortization | |
| Share-based compensation | |
| Amortization of debt discount and debt issuance costs | |
| Remeasurement of warrant to fair value | |
| Impairment of long-lived assets | |
| Provision for credit losses | |
| Non-cash foreign currency exchange (gain) loss, net | |
| (Gain) loss on deconsolidation of subsidiaries and related adjustments | |
| Write-off of unamortized debt discount and debt issuance costs | |
| Gain on disposal of business | |
| Deferred income taxes | |
| Gain from remeasurement of previous equity interest | |
| Other operating activities, net | |
| Changes in assets and liabilities: | |
| Trade and other receivables, net | |
| Prepaid expenses and other current assets | |
| Accounts payable and other current liabilities | |
| Operating leases, net | |
| Other noncurrent assets and liabilities | |
| Net cash provided by (used in) operating activities | |
| Investing Activities: | |
| Acquisition of businesses, net of cash acquired | |
| Payment for asset acquisition | |
| Proceeds from sale of business, net of cash disposed | |
| Additions to property and equipment | |
| Additions to intangible assets | |
| Cash deconsolidated from previously controlled subsidiary | |
| Other investing activities, net | |
| Net cash (used in) provided by investing activities | |
| Financing Activities: | |
| Proceeds from issuance of debt and borrowings under revolving credit facility | |
| Repayments of debt and borrowings under revolving credit facility | |
| Debt issuance costs paid | |
| Capital contribution from Parent | |
| Proceeds from initial public offering, net of underwriters discounts and commissions | |
| Payments of deferred offering costs | |
| Finance leases | |
| Cash dividends paid to noncontrolling interests | |
| Other financing activities, net | |
| Net cash provided by (used in) financing activities | |
| Effect of exchange-rate changes on cash and cash equivalents | |
| Net increase (decrease) in cash and cash equivalents | |
| Cash and cash equivalents at beginning of period | |
| Cash and cash equivalents at end of period | |
| Less: cash and cash equivalents included in current assets held for sale | |
| Cash and cash equivalents at end of period as reported on consolidated balance sheet | |
| Supplemental Disclosures of Cash Flow Information: | |
| Cash paid for interest | |
| Cash paid for income taxes, net of refunds received | |
| Supplemental Disclosures of Non-Cash Items: | |
| Reclassification of warrant from liability to equity | |
| Reclassification of phantom awards from liability to equity | |
| Capital expenditures in accounts payable |
Loading...
